Sponsor or institution
Clinical trials and research at Laboratoires Thea
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Laboratoires Thea that are recruiting, at sites in 15 countries (most in India (1), Jordan (1), South Africa (1)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 15Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| T10430 eye drops to slow childhood myopia progression | Phase 2 | Amman and 9 other locations | Recruiting | Apr 13, 2026 |
| Tracking eye-drop use with CONNECTDROP® for people with glaucoma | — | Bologna and 14 other locations | Recruiting | Oct 3, 2025 |
| T1695 versus ciclosporin for moderate to severe vernal keratoconjunctivitis in children and teenagers | Phase 2 | Kolkata, West Bengal and 10 other locations | Recruiting | Sep 12, 2025 |
| Sepofarsen injections for LCA10 due to the CEP290 p.Cys998X mutation | Phase 3 | San Francisco, California and 17 other locations | Recruiting | Mar 24, 2025 |
All recruiting trials (4)
-
T10430 eye drops to slow childhood myopia progression
We will test whether T10430 eye drops can slow worsening nearsightedness in children aged 6 to 11.
-
Tracking eye-drop use with CONNECTDROP® for people with glaucoma
This project will try using the CONNECTDROP® smart device and smartphone app to track daily eye-drop use in adults with open-angle glaucoma to measure how well they follow their prescribed treatment.
-
T1695 versus ciclosporin for moderate to severe vernal keratoconjunctivitis in children and teenagers
This study will test whether T1695 eye treatment works better and is as safe as ciclosporin for kids and teens (ages 4–17) with moderate to severe vernal keratoconjunctivitis.
-
Sepofarsen injections for LCA10 due to the CEP290 p.Cys998X mutation
This study will test whether sepofarsen eye injections can improve vision in children and adults with LCA10 caused by the CEP290 c.2991+1655A>G (p.Cys998X) mutation.
Quick answers
How many clinical trials run by Laboratoires Thea are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in India (1 trial), Jordan (1 trial), South Africa (1 trial), Tunisia (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.